Breast Cancer
Feature
How useful are circulating tumor cells for early diagnosis?
Their link with metastases, and thus with aggressive tumors, gives them an advantage over other (noninvasive or minimally invasive) biomarkers in...
Commentary
Considering the true costs of clinical trials
There are many subtle and some egregious ways that participating in clinical trials can result in increased costs.
From the Journals
PPIs may curb benefits of palbociclib in breast cancer
“The findings suggest that taking PPIs with palbociclib may interrupt the full therapeutic benefits of palbociclib,” the authors conclude.
Latest News
Black women weigh emerging risks of ‘creamy crack’ hair straighteners
Mounting evidence now shows that chemical straighteners could be a health hazard.
From the Journals
AI-supported breast screens may reduce radiologist workload
The potential for overdiagnosis or overdetection of indolent lesions in the intervention group should “prompt caution in the interpretation of...
From the Journals
Cancer diagnoses, care access rise after Medicaid expansion
In Ohio, researchers found a substantial increase in diagnoses for all three cancers among Medicaid patients after expansion.
Latest News
Oncologists challenge ‘burdensome’ MOC requirements
“It’s a pain-in-the-ass module that you sit at home and Google – it’s not really any sort of assessment,” nor does it help protect the public.
Commentary
Who owns your genes?
The assumption of any sane person would be that he or she owns his or her own genes. I mean, how dumb a question is that?
Commentary
The unique approach involved in age-specific concerns surrounding young patients with breast cancer
We need to take care of many things, which can go from their job, family, fertility, and all these things are specific to these women and can...
Latest News
Fatalities from breast cancer have ‘improved substantially’
Women diagnosed with early-stage breast cancer are more likely to become long-term survivors of the disease now than they were 20 years ago.
From the Journals
DCIS isn’t an automatic indication for mastectomy in HER2+ BC
In the largest look into the issue to date, investigators find that neoadjuvant therapy clears DCIS about half of the time.